Reunion Neuroscience, Inc.
through Sep 9, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | May 5, 2025 · D/A | Sep 9, 2025 · D/A | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $89,850,000 | $119,850,000 | $30,000,000 |
| Reported amount sold | $68,880,305 | $119,850,000 | $50,969,695 |
| Reported investor count | — | — | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0002007993-25-000003 · Later SEC source: 0002007993-25-000004
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $119,850,000
- Reported amount sold
- $119,850,000
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Contact info
Log in to look up an email or website for this issuer.
Form D filings (2)
-
0002007993-25-000004D/A · Sep 9, 2025 · PharmaceuticalsOffering: $119,850,000Sold: $119,850,000
-
0002007993-25-000003D/A · May 5, 2025 · PharmaceuticalsOffering: $89,850,000Sold: $68,880,305